6.22

1.74% -0.11

After Hours: 6.23 0.01 +0.16%

Precision Biosciences Inc (DTIL)

Overview News Price History Option Chain Financials Discussions Forecast

Precision Biosciences Inc stock is traded at $6.22, with a volume of 203.97K. It is down -1.74% in the last 24 hours and down -27.25% over the past month. Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Previous Close:

$6.33

Open:

$6.35

24h Volume:

203.97K

Relative Volume:

0.52

Market Cap:

$171.68M

Revenue:

$45.07M

Net Income/Loss:

$-44.49M

P/E Ratio:

-1.6738

EPS:

-3.716

Net Cash Flow:

$-54.23M

1W Performance:

-6.75%

1M Performance:

-27.25%

6M Performance:

-3.86%

1Y Performance:

+26.17%

1-Day Range:

$6.18

$6.55

1-Week Range:

$6.18

$7.3126

52-Week Range:

$3.53

$9.62

Precision Biosciences Inc Stock (DTIL) Company Profile

Name

Precision Biosciences Inc

Sector

Healthcare (1067)

Industry

Biotechnology (595)

Phone

919-314-5512

Address

302 EAST PETTIGREW STREET, DURHAM, NC

Employee

Twitter

@PrecisionBioSci

Next Earnings Date

2026-11-02

Latest SEC Filings

DTIL's Discussions on Twitter

Compare DTIL vs VRTX, REGN, MRNA, ARGX, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DTIL Precision Biosciences Inc	6.22	171.68M	45.07M	-44.49M	-54.23M	-3.716
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-25	Upgrade	BMO Capital Markets	Market Perform → Outperform
Apr-30-24	Initiated	Guggenheim	Buy
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Jun-09-22	Downgrade	William Blair	Outperform → Mkt Perform
Jul-27-20	Resumed	BTIG Research	Buy
Apr-03-20	Downgrade	Goldman	Buy → Neutral
Mar-05-20	Initiated	Stifel	Buy
Feb-25-20	Initiated	William Blair	Outperform
Aug-09-19	Initiated	BTIG Research	Buy
Jul-16-19	Initiated	H.C. Wainwright	Buy
Apr-22-19	Initiated	Barclays	Overweight
Apr-22-19	Initiated	Goldman	Buy
Apr-22-19	Initiated	JP Morgan	Overweight
Apr-22-19	Initiated	Jefferies	Buy

View All

Precision Biosciences Inc Stock (DTIL) Latest News

02:30 AM

How Precision Biosciences Inc. (DTIL) Affects Rotational Strategy Timing - Stock Traders Daily

02:30 AM

Sep 24, 2026

Precision BioSciences (DTIL) Short Interest & Short Float | Updated Sep 2026 $DTIL - MarketBeat

Sep 24, 2026

Sep 22, 2026

Precision Biosciences stock holds its Nasdaq listing - AD HOC NEWS

Sep 22, 2026

Sep 20, 2026

Precision BioSciences, Inc.(NasdaqCM: DTIL) added to S&P Global BMI Index - marketscreener.com

Sep 20, 2026

Sep 19, 2026

Precision BioSciences stock trades quietly amid lack of fresh catalysts - AD HOC NEWS

Sep 19, 2026

Sep 18, 2026